Status:
UNKNOWN
Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14
Lead Sponsor:
Orpha Labs
Conditions:
Glycogen Storage Disease, Type 14
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE1
PHASE2
Brief Summary
Study of ORL-1G in Patients With Glycogen Storage Disease Type 14
Eligibility Criteria
Inclusion
- Diagnosis of Glycogen Storage Disease Type 14.
- Less than 18 years old.
Exclusion
- Diagnosis of any other disease that is not a manifestation of Glycogen Storage Disease Type 14.
Key Trial Info
Start Date :
October 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2019
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03404856
Start Date
October 31 2017
End Date
October 31 2019
Last Update
January 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orpha Labs
Ankara, Turkey (Türkiye), 06100